Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression

Correction to: Cell Death and Disease 10.1038/s41419-022-04573-7, published online 03 February 2022.

The original version of this article contained a mistake in figure 8. The correct figure can be found below. The original article has been corrected.